Skip to Content

305 (Pramipexole Dihydrochloride Extended-Release 2.25 mg)

Pill with imprint 305 is White, Elliptical / Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 2.25 mg. It is supplied by Par Pharmaceutical, Inc..

Pramipexole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 2.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 305

Pramipexole Dihydrochloride Extended-Release

Imprint:
305
Strength:
2.25 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Par Pharmaceutical, Inc.
National Drug Code (NDC):
10370-0305

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide